Bluejay Diagnostics, Inc. (BJDX) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BJDX Revenue Growth
BJDX Revenue Analysis (2019–2024)
As of May 8, 2026, Bluejay Diagnostics, Inc. (BJDX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, BJDX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $249,040 in 2022.
When compared to Healthcare sector peers including QDEL (-3.9% YoY), CUE (+195.7% YoY), and LFMD (-6.2% YoY). Compare BJDX vs QDEL →
BJDX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BJDXCurrent | $0 | - | - | - | |
 QDEL | $2.7B | -3.9% | +10.4% | -33.7% | |
 CUE | $27M | +195.7% | +54.2% | -96.7% | |
 LFMD | $194M | -6.2% | +39.1% | -4.0% | |
 IDXX | $4.3B | +13.1% | +9.7% | 31.6% | |
 OSUR | $115M | -47.3% | -7.7% | -59.2% |
BJDX Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-7,169,616 | - |
| 2023 | $0 | -100.0% | $0 | - | $-10,311,217 | - |
| 2022 | $249K | - | $49K | 19.6% | $-9,317,776 | -3741.5% |
| 2021 | $0 | - | $-145,719 | - | $-3,230,163 | - |
| 2020 | $0 | - | $-157,039 | - | $-1,196,391 | - |
| 2019 | $0 | - | $-142,975 | - | $-1,631,413 | - |
See BJDX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BJDX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BJDX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBJDX — Frequently Asked Questions
Quick answers to the most common questions about buying BJDX stock.
Is BJDX's revenue growth accelerating or slowing?
BJDX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is BJDX's long-term revenue growth rate?
Bluejay Diagnostics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is BJDX's revenue distributed by segment?
BJDX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.